0001437749-17-018054.txt : 20171101
0001437749-17-018054.hdr.sgml : 20171101
20171101171426
ACCESSION NUMBER: 0001437749-17-018054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171030
FILED AS OF DATE: 20171101
DATE AS OF CHANGE: 20171101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SARGEN GREGORY
CENTRAL INDEX KEY: 0001227835
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10638
FILM NUMBER: 171169874
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAMBREX CORP
CENTRAL INDEX KEY: 0000820081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222476135
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MEADOWLANDS PLZ
CITY: E RUTHERFORD
STATE: NJ
ZIP: 07073
BUSINESS PHONE: 2018043000
MAIL ADDRESS:
STREET 1: ONE MEADOWLANDS PLAZA
CITY: E. RUTHERFORD
STATE: NJ
ZIP: 07073
4
1
rdgdoc.xml
FORM 4
X0306
4
2017-10-30
0000820081
CAMBREX CORP
CBM
0001227835
SARGEN GREGORY
ONE MEADOWLANDS PLAZA
EAST RUTHERFORD
NJ
07073
1
EVP, Corporate Development
Stock Option (right to buy)
45.635
2017-10-30
4
A
0
25000
0
A
2024-10-30
Common Stock
25000
25000
D
The option representing a right to purchase a total of 25,000 shares becomes exercisable in four equal installments beginning October 30, 2018, which is the first anniversary of the date on which the option was granted.
/s/ Danielle Mann for Gregory P. Sargen by POA
2017-11-01